Drug Shortage Report for MYLAN-ATORVASTATIN
| Report ID | 25898 |
| Drug Identification Number | 02392941 |
| Brand name | MYLAN-ATORVASTATIN |
| Common or Proper name | ATORVASTATIN |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | ATORVASTATIN |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 90BT, 500BT |
| ATC code | C10AA |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2018-10-15 |
| Actual start date | |
| Estimated end date | 2018-10-19 |
| Actual end date | 2018-10-15 |
| Shortage status | Resolved |
| Updated date | 2018-10-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v13 | 2018-07-31 | French | Compare |
| v12 | 2018-07-31 | English | Compare |
| v11 | 2018-01-23 | French | Compare |
| v10 | 2018-01-23 | English | Compare |
| v9 | 2017-10-27 | French | Compare |
| v8 | 2017-10-27 | English | Compare |
| v7 | 2017-10-27 | French | Compare |
| v6 | 2017-10-27 | English | Compare |
| v5 | 2017-10-13 | French | Compare |
| v4 | 2017-10-13 | English | Compare |
| v3 | 2017-10-13 | French | Compare |
| v2 | 2017-10-13 | English | Compare |
| v1 | 2017-10-13 | English | Compare |